A Study To Assess Absorption Of Study Drug Dacomitinib (PF-00299804), Given As An Oral Tablet Compared To An Intravenous Infusion In Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions

Healthy Volunteers

Interventions

DRUG

dacomitinib oral

Dacomitinib 45 mg oral tablet

DRUG

dacomitinib intravenous

Dacomitinib 20 mg solution will be given as 1 hour intravenous infusion

Trial Locations (1)

Pfizer Investigational Site, Ruddington Fields